Bristol Myers Squibb (BMS) has operationalized the voluntary and private collection of Sexual Orientation and Gender Identity (SOGI) data for adult patients in their US clinical trials. BMS’ Lorena Kuri, Donna Sattler and Jessica Brescher walk us through achieving this, why it matters so much, and call upon other companies to do the same.
Lead Editorial
BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity
Editorial by Category
Clinical Trial Operations
View All
Clinical Trial Professionals on Automation: Where It's Useful and How Pharma Can Take Better Advantage
DPHARM® Launches 2024 Event Addressing Innovation to Manage Clinical Trials Complexity, Capabilities Gaps and Costs
Strengthening Patient-Sponsor Ties and Helping Communities Create Legacies of Health
BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity
Immuno-Oncology and Cell Therapy
View All
Drug Delivery
View All
AbbVie’s Global Head of Complex Devices and Delivery Systems on Regulatory Challenges in New Delivery Device Approval
How Harvard is Building Machine Learning Models to Better Identify Targets and Design Drugs
PODD Announces the 2024 Keynotes and Early Agenda
PODD 2023: Combination Product Development Approaches with Pfizer, Genentech, AstraZeneca, Kymanox and Windgap Medical
Patients as Partners in Clinical Research and Patient Access
View All
AbbVie’s Director of Clinical Study Patient Platforms on Supporting Patients in Decentralized Trials
Making Clinical Trials More Inclusive for Sex- and Gender-Diverse People
BMS and the LGBTQ+ Community Improve Clinical Data to Achieve Health Equity
From the Archive: How Sanofi’s Integration of the Patient Voice Impacted Recruitment, Protocols and Time to Market
Biotech CMO/R&D Leadership
View All
Communication Strategies for CMOs to Support Drug Development
Dr Roy Baynes on Strategy Development for Keytruda
A Former CMO on How to Best Partner with Hospitals Bringing Early Phase Clinical Research to Under-Resourced Patient Populations
Bolt Biotherapeutics' CMO on Her Career Journey and Advice for Women in Science
CRAACO: Clinical Research as a Care Option
View All
Pfizer’s Digital Health Approach to Generate Better Endpoints
CRAACO® 2024 Conference Reports on the Convergence Journey of Clinical Research and Clinical Care
Duke on Creating a Career Path to Address Clinical Trial Workforce Challenges
